Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

British Journal of Haematology

Volumn 116, Issue 2, 2002, Pages 465-467

  Nobili, Bruno ^a   Cennamo, Lucia ^a   La Manna, Angela ^a   Perrotta, Silverio ^a   De Stefano, Piero ^b   Locatelli, Franco ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autoimmune haemolytic anaemia; Autoimmunity; B lymphocytes; Rituximab; Systemic lupus erythematosus

Indexed keywords

CD20 ANTIGEN; CYCLOSPORIN A; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; RITUXIMAB; STEROID;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; CASE REPORT; DISEASE COURSE; DRUG TOLERANCE; FEMALE; HEMOGLOBIN DETERMINATION; HEMOLYTIC ANEMIA; HUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT;

EID: 0036180868     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2001.03278.x     Document Type: Article

References (12)

1. Acute hepatitis B in a patients with antibodies to hepatitis B surface antigen who was receiving Rituximab
2. Treatment with anti-CD20 antibodies of patients with autoimmune thrombocytopenia with or without haemolytic anemia; worsening in hemoglobin level
3. Hematological manifestations of systemic lupus erythemathosus
4. Rituxan in the treatment of cold agglutinin disease
5. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
6. Rituximab, cyclophosphamide and decadron combination is highly effective in auto-immune hemolytic anemia associated with chronic lymphocytic leukemia
7. Depletion of B-cells in vivo by a chimeric mouse monoclonal antibody to CD20
8. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
9. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab
10. Rituximab for myasthenia gravis developing after bone marrow transplant
11. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anaemia
12. Damage in systemic lupus erythemathosus and its' association with corticosteroids